These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Staphostatins: an expanding new group of proteinase inhibitors with a unique specificity for the regulation of staphopains, Staphylococcus spp. cysteine proteinases. Rzychon M; Sabat A; Kosowska K; Potempa J; Dubin A Mol Microbiol; 2003 Aug; 49(4):1051-66. PubMed ID: 12890028 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of human extracellular cysteine protease inhibitors by the secreted staphylococcal cysteine proteases, staphopain A and B. Vincents B; Onnerfjord P; Gruca M; Potempa J; Abrahamson M Biol Chem; 2007 Apr; 388(4):437-46. PubMed ID: 17391065 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Staphylococcus aureus cysteine proteases by human serpin potentially limits staphylococcal virulence. Kantyka T; Plaza K; Koziel J; Florczyk D; Stennicke HR; Thogersen IB; Enghild JJ; Silverman GA; Pak SC; Potempa J Biol Chem; 2011 May; 392(5):483-9. PubMed ID: 21476872 [TBL] [Abstract][Full Text] [Related]
10. Galectin-3 Is a Target for Proteases Involved in the Virulence of Staphylococcus aureus. Elmwall J; Kwiecinski J; Na M; Ali AA; Osla V; Shaw LN; Wang W; Sävman K; Josefsson E; Bylund J; Jin T; Welin A; Karlsson A Infect Immun; 2017 Jul; 85(7):. PubMed ID: 28438975 [No Abstract] [Full Text] [Related]
11. Prevalence of genes encoding extracellular proteases in Staphylococcus aureus - important targets triggering immune response in vivo. Zdzalik M; Karim AY; Wolski K; Buda P; Wojcik K; Brueggemann S; Wojciechowski P; Eick S; Calander AM; Jonsson IM; Kubica M; Polakowska K; Miedzobrodzki J; Wladyka B; Potempa J; Dubin G FEMS Immunol Med Microbiol; 2012 Nov; 66(2):220-9. PubMed ID: 22762789 [TBL] [Abstract][Full Text] [Related]
12. A comparison of staphostatin B with standard mechanism serine protease inhibitors. Filipek R; Potempa J; Bochtler M J Biol Chem; 2005 Apr; 280(15):14669-74. PubMed ID: 15644332 [TBL] [Abstract][Full Text] [Related]
13. Unraveling the Impact of Secreted Proteases on Hypervirulence in Gimza BD; Jackson JK; Frey AM; Budny BG; Chaput D; Rizzo DN; Shaw LN mBio; 2021 Feb; 12(1):. PubMed ID: 33622717 [No Abstract] [Full Text] [Related]
15. Defense against own arms: staphylococcal cysteine proteases and their inhibitors. Dubin G Acta Biochim Pol; 2003; 50(3):715-24. PubMed ID: 14515151 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains. Rigoulay C; Entenza JM; Halpern D; Widmer E; Moreillon P; Poquet I; Gruss A Infect Immun; 2005 Jan; 73(1):563-72. PubMed ID: 15618196 [TBL] [Abstract][Full Text] [Related]
18. Global regulatory impact of ClpP protease of Staphylococcus aureus on regulons involved in virulence, oxidative stress response, autolysis, and DNA repair. Michel A; Agerer F; Hauck CR; Herrmann M; Ullrich J; Hacker J; Ohlsen K J Bacteriol; 2006 Aug; 188(16):5783-96. PubMed ID: 16885446 [TBL] [Abstract][Full Text] [Related]
19. Efficient co-expression of a recombinant staphopain A and its inhibitor staphostatin A in Escherichia coli. Wladyka B; Puzia K; Dubin A Biochem J; 2005 Jan; 385(Pt 1):181-7. PubMed ID: 15320867 [TBL] [Abstract][Full Text] [Related]
20. Global virulence regulation in Staphylococcus aureus: pinpointing the roles of ClpP and ClpX in the sar/agr regulatory network. Frees D; Sørensen K; Ingmer H Infect Immun; 2005 Dec; 73(12):8100-8. PubMed ID: 16299304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]